Analysis of the input of polymorphism of several candidate genes in the development of hypertension and myocardial remodeling: in the sample of sibling pairs
https://doi.org/10.18705/1607-419X-2011-17-5-488-492
Abstract
About the Authors
N. R. KhasanovRussian Federation
V. N. Oslopov
Russian Federation
P. A. Slominskiy
Russian Federation
References
1. Mom T., Al Balushi K.A. Genetic variations related to hypertension: a review // J. Hum. Hypertens. — 2005. — Vol. 19, № 1. — P. 7-19.
2. Sethi A.A., Nordestgaard B.G., Tybjærg-Hansen A. Angiotensinogen gene polymorphism, plasma angiotensinogen, and risk of hypertension and ischemic heart disease: meta-analysis // Arterioscler. Thromb. Vasc. Biol. — 2003. — Vol. 23, № 7. — P. 1269-1275.
3. Rankinen T., Gagnon J., Perusse L. et al. AGT M235T and ACE ID polymorphisms and exercise blood pressure in the HERITAGE Family Study // Am. J. Physiol. Heart Circul. Physiol. — 2000. — Vol. 279, № 1. — P. H368-H374.
4. Saeed M., Siddiqui S., Khan A. et al. Association of ACE polymorphism with left ventricular hypertrophy // Neuroendocrinol. Letters. — 2005. — Vol. 26, № 4. — P. 393-396.
5. Baker M., Rahman T., Hall D. et al. The C-532T polymorphism of the angiotensinogen gene is associated with pulse pressure: A possible explanation for heterogeneity in genetic association studies of AGT and hypertension // Int. J. Epidemiol. — 2007. — Vol. 36, № 6. — P. 1356-1362.
6. Stavroulakis G.A., Makris T.K., Krespi P.G. et al. Predicting response to chronic antihypertensive treatment with fosinopril: the role of angiotensin-converting enzyme gene polymorphism // Cardiovasc. Drugs Ther. — 2000. — Vol. 14, № 4. — P. 427-432.
7. Zintzaras E., Kitsios G., Stefanidis I. Endothelial NO syntase gene polymorphism and hypertension: a meta-analysis // Hypertension. — 2006. — Vol. 48, № 4. — P. 700-710.
8. Bengtsson K., Melander O., Orho-Melander M. et al. Polymorphism in the β1-adrenergic receptor gene and hypertension // Circulation. — 2001. — Vol. 104, № 2. — Р. 187-190.
9. Gluba A., Banach M., Mikhailidis D.P., Rysz J. Genetic determinants of cardiovascular disease: the renin-angiotensin-aldosterone system, paraoxonases, endothelin-1, nitric oxide synthase and adrenergic receptors // In Vivo. — 2009. — Vol. 23, № 5. — P. 797-812.
10. Kang B.Y., Bae J.S., Kim K.T. et al. Apolipoprotein(a) gene polymorphism in the Korean population: Is there any revelance to essential hypertension? // Med. Principles Practice. — 2002. — Vol. 11, № 2. — P. 69-74.
11. Li X., Du Y., Du Y., Huang X. Association of apolipoprotein E gene polymorphism with essential hypertension and its complications // Clin. Experim. Med. — 2003. — Vol. 2, № 4. — P. 175-179.
12. Yamada Y., Kato K., Yoshida T. et al. Association of polymorphisms of ABCA1 and ROS1 with hypertension in Japanese individuals // Int. J. Mol. Med. — 2008. — Vol. 21, № 1. — P. 83-89.
13. Xu M., Zhou H., Gu Q., Li C. The expression of ATP-binding cassette transporters in hypertensive patients // Hypertens. Res. — 2009. — Vol. 32, № 6. — P. 455-461.
14. Agerholm-Larsen B., Borge G., Tybjærg-Hansen N., Tybjærg-Hansen A. ACE gene polymorphism in cardiovascular disease: meta- analyses of small and large studies in whites // Arterioscler. Thromb. Vasc. Biol. — 2000. — Vol. 20, № 2. — P. 484-492.
15. Motawi T., Shaker O., Taha M. et al. Endothelial nitric oxide synthase and angiotensinogen gene polymorphism in coronary artery diseases in Egypt // Angiology. — 2011. — Vol. 62, № 2. — Р. 191-197.
16. Беркович О.А., Баженова Е.А., Вахрамеева Н.В. и др. Полиморфизм генов ренин-ангиотензиновой системы и дисфункция эндотелия у мужчин, перенесших инфаркт миокарда в молодом возрасте // Артериальная гипертензия. — 2008. — Т. 14, № 3. — С. 239-244.
17. Higashi Y., Noma K., Yoshizumi M. et al. Endothelial function and oxidative stress in cardiovascular diseases // Circ. J. — 2009. — Vol. 73, № 3. — P. 411-418.
18. Timberlake D.S., O'Conner D.T., Parmer R.J. Molecular genetics of essential hypertension: recent results and emerging strategies // Cur. Opin. Nephrol. Hypertens. — 2001. — Vol. 10, № 1. — P. 71-79.
19. Caulfield M., Munroe P., Pembroke J. et al. Genome-wide mapping of human loci for essential hypertension // Lancet. — 2003. — Vol. 361, № 9375. — P. 2118-2123.
20. Аронов Д.М., Лимборская С.А., Юферева Ю.М. и др. Анализ вклада инсерционно-делеционного полиморфизма гена ангиотензин-превращающего фермента в развитие коронарной болезни сердца // Кардиоваск. тер. профилакт. — 2004. — Т. 3, № 5. — С. 52-59.
21. Диагностика и лечение артериальной гипертензии. Рекомендации Российского медицинского общества по артериальной гипертонии и Всероссийского научного общества кардиологов (третий пересмотр) // Кардиоваск. тер. профилакт. — 2008. — Т. 7, № 6, прил. 2. — С. 1-31.
22. Sambrook J., Fritsch E.F., Maniatis T. Molecular doning: a laboratory manual. — 2nd ed. — N.Y.: Cold Spring Harbor Laboratory, Cold Spring Harbor Laboratory Press, 1989. — 1659 p.
23. Curtis D., Miller M.B., Sham P.C. Combining the sibling disequilibrium test and transmission/disequilibrium test for multiallelic markers // Am. J. Hum. Gen. — 1999. — Vol. 64, № 6. — P. 1785-1786.
24. Bland J.M., Altman D.G. Statistics notes: The odds ratio // Br. Med. J. — 2000. — Vol. 27, № 7247. — P. 1468.
25. Bisoendial R.J., Hovingh G.K., Levels J.H.M. et al. Restoration of endothelial function by increasing high-density lipoprotein in subjects with isolated low high-density lipoprotein // Circulation. — 2003. — Vol. 107, № 23. — P. 2944-2948.
26. Rhoderick Y.R., Thompson C.M., Bridges R.J. Functional expression, purification and high sequence coverage mass spectrometric characterization of human excitatory amino acid transporter EAAT2 // Protein Expr. Purif. — 2010. — Vol. 74, № 1. — P. 49-59.
27. Гусев Е.И., Скворцова В.И. Ишемия головного мозга. — М.: Медицина, 2001. — 328 с.
28. Parfenova H., Fedinec A., Leffler C.W. Ionotropic glutamate receptors in cerebral microvascular endothelium are functionally linked to heme oxygenase // J. Cereb. Blood Flow Metab. — 2003. — Vol. 23, № 2. — P. 190-197.
29. Sullivan J.M., Prewitt R.I., Josephs J.A. Attenuation of the microcirculation in young patients with high-output borderline hypertension // Hypertension. — 1983. — Vol. 5, № 6. — P. 844-851.
30. Susian S.A., Lorenzo H.K., Zamzami N. et al. Molecular characterization of mitochondrial apoptosis-inducing factor // Nature. — 1999. — Vol. 397, № 6718. — P. 441-446.
31. Hangen E., Blomgren K., Benit P. et al. Life with or without AIF // Trends Biochem. Sci. — 2010. — Vol. 35, № 5. — P. 278-287.
32. Постнов Ю.В., Орлов С.Н., Будников Е.Ю. и др. Нарушение преобразования энергии в митохондриях клеток с уменьшением синтеза АТФ как причина стационарного повышения уровня системного артериального давления // Кардиология. — 2008. — Т. 48, № 8. — С. 49-59.
Review
For citations:
Khasanov N.R., Oslopov V.N., Slominskiy P.A. Analysis of the input of polymorphism of several candidate genes in the development of hypertension and myocardial remodeling: in the sample of sibling pairs. "Arterial’naya Gipertenziya" ("Arterial Hypertension"). 2011;17(5):488-492. (In Russ.) https://doi.org/10.18705/1607-419X-2011-17-5-488-492